These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 22765255)

  • 21. Mapping the Minnesota living with heart failure questionnaire (MLHFQ) to EQ-5D-5L in patients with heart failure.
    Kularatna S; Senanayake S; Chen G; Parsonage W
    Health Qual Life Outcomes; 2020 Apr; 18(1):115. PubMed ID: 32349782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indirect and Direct Mapping of the Cancer-Specific EORTC QLQ-C30 onto EQ-5D-5L Utility Scores.
    Meunier A; Soare A; Chevrou-Severac H; Myren KJ; Murata T; Longworth L
    Appl Health Econ Health Policy; 2022 Jan; 20(1):119-131. PubMed ID: 34554442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Catalog and comparison of societal preferences (utilities) for lung cancer health states: results from the Cancer Care Outcomes Research and Surveillance (CanCORS) study.
    Tramontano AC; Schrag DL; Malin JK; Miller MC; Weeks JC; Swan JS; McMahon PM
    Med Decis Making; 2015 Apr; 35(3):371-87. PubMed ID: 25670839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mapping analysis to predict EQ-5D-5 L utility values based on the Oxford Hip Score (OHS) and Oxford Knee Score (OKS) questionnaires in the Spanish population suffering from lower limb osteoarthritis.
    Martín-Fernández J; Morey-Montalvo M; Tomás-García N; Martín-Ramos E; Muñoz-García JC; Polentinos-Castro E; Rodríguez-Martínez G; Arenaza JC; García-Pérez L; Magdalena-Armas L; Bilbao A
    Health Qual Life Outcomes; 2020 Jun; 18(1):184. PubMed ID: 32539838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EQ-5D-3L health status and health state utilities of the oldest-old (85 +) in Germany: results from the AgeCoDe-AgeQualiDe study.
    König HH; Brettschneider C; Lühmann D; Kaduszkiewicz H; Oey A; Wiese B; Werle J; Weyerer S; Fuchs A; Pentzek M; Conrad I; Röhr S; Weeg D; Bickel H; Heser K; Wagner M; Scherer M; Maier W; Riedel-Heller SG; Hajek A
    Qual Life Res; 2020 Dec; 29(12):3223-3232. PubMed ID: 32851600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can Mapping Algorithms Based on Raw Scores Overestimate QALYs Gained by Treatment? A Comparison of Mappings Between the Roland-Morris Disability Questionnaire and the EQ-5D-3L Based on Raw and Differenced Score Data.
    Madan J; Khan KA; Petrou S; Lamb SE
    Pharmacoeconomics; 2017 May; 35(5):549-559. PubMed ID: 28063083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping painDETECT, a neuropathic pain screening tool, to the EuroQol (EQ-5D-3L).
    Cappelleri JC; Koduru V; Bienen EJ; Sadosky A
    Qual Life Res; 2017 Feb; 26(2):467-477. PubMed ID: 27485915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimating the association between SF-12 responses and EQ-5D utility values by response mapping.
    Gray AM; Rivero-Arias O; Clarke PM
    Med Decis Making; 2006; 26(1):18-29. PubMed ID: 16495197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testing alternative regression models to predict utilities: mapping the QLQ-C30 onto the EQ-5D-5L and the SF-6D.
    Lamu AN; Olsen JA
    Qual Life Res; 2018 Nov; 27(11):2823-2839. PubMed ID: 30173314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping QLQ-C30, HAQ, and MSIS-29 on EQ-5D.
    Versteegh MM; Leunis A; Luime JJ; Boggild M; Uyl-de Groot CA; Stolk EA
    Med Decis Making; 2012; 32(4):554-68. PubMed ID: 22114301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting the EuroQol Group's EQ-5D index from CDC's "Healthy Days" in a US sample.
    Jia H; Zack MM; Moriarty DG; Fryback DG
    Med Decis Making; 2011; 31(1):174-85. PubMed ID: 20375418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis.
    Wong CKH; Cheung PWH; Samartzis D; Luk KD; Cheung KMC; Lam CLK; Cheung JPY
    PLoS One; 2017; 12(4):e0175847. PubMed ID: 28414745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of the minimum clinically important difference in pain, disability, and quality of life after anterior cervical discectomy and fusion: clinical article.
    Parker SL; Godil SS; Shau DN; Mendenhall SK; McGirt MJ
    J Neurosurg Spine; 2013 Feb; 18(2):154-60. PubMed ID: 23176164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimating EQ-5D and OAB-5D health state utilities for patients with overactive bladder.
    Desroziers K; Aballéa S; Maman K; Nazir J; Odeyemi I; Hakimi Z
    Health Qual Life Outcomes; 2013 Nov; 11():200. PubMed ID: 24246044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of FACT- and EQ-5D-based utility scores in cancer.
    Pickard AS; Ray S; Ganguli A; Cella D
    Value Health; 2012; 15(2):305-11. PubMed ID: 22433762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obtaining EQ-5D-3L utility index from the health status scale of traditional Chinese medicine (TCM-HSS) based on a mapping study.
    Wang L; Lu Y; Dai Z; Shi P; Xu J; Chang F; Lu Y
    Health Qual Life Outcomes; 2022 Dec; 20(1):164. PubMed ID: 36522665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mapping the PHQ-8 to EQ-5D, HUI3 and SF6D in patients with depression.
    Abdin E; Chong SA; Seow E; Tan KB; Subramaniam M
    BMC Psychiatry; 2021 Sep; 21(1):451. PubMed ID: 34517871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?
    Rutten-van Mölken MP; Oostenbrink JB; Tashkin DP; Burkhart D; Monz BU
    Chest; 2006 Oct; 130(4):1117-28. PubMed ID: 17035446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting the EQ-5D utilities from the Kansas City Cardiomyopathy Questionnaire in patients with heart failure.
    Thomas M; Jones PG; Cohen DJ; Suzanne AV; Magnuson EA; Wang K; Thourani VH; Fonarow GC; Sandhu AT; Spertus JA
    Eur Heart J Qual Care Clin Outcomes; 2021 Jul; 7(4):388-396. PubMed ID: 33724402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis.
    Davison NJ; Thompson AJ; Turner AJ; Longworth L; McElhone K; Griffiths CEM; Payne K;
    Value Health; 2018 Aug; 21(8):1010-1018. PubMed ID: 30098665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.